Published in Lung India on July 01, 2014
Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature. Ocul Oncol Pathol (2016) 0.75
Establishment and identification of human primary lung cancer cell culture in vitro. Int J Clin Exp Pathol (2015) 0.75
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK. J Clin Oncol (2009) 15.23
Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations. J Clin Oncol (2011) 4.37
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med (2013) 2.66
Screening for EGFR mutations in lung cancer, a report from India. Lung Cancer (2011) 1.96
Metastatic non-small-cell lung cancer: consensus on pathology and molecular tests, first-line, second-line, and third-line therapy: 1st ESMO Consensus Conference in Lung Cancer; Lugano 2010. Ann Oncol (2011) 1.73
Clinical utility of cytokeratins as tumor markers. Clin Biochem (2004) 1.63
Lung cancer working group report. Jpn J Clin Oncol (2010) 0.98
A comparative study of telomerase activity in sputum, bronchial washing and biopsy specimens of lung cancer. Lung Cancer (2001) 0.89
Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy. Lung Cancer (2010) 0.88
Non small cell lung cancer (NSCLC): current status and future prospects. Indian J Chest Dis Allied Sci (2004) 0.86
Significance of tumor markers in lung cancer. Indian J Clin Biochem (2006) 0.86
Telomerase activity in sputum and telomerase and its components in biopsies of advanced lung cancer. Eur J Cancer (2007) 0.85
Immunohistochemical staining on fine needle aspiration biopsy-cell block specimens in the differential diagnosis of lung cancers. Indian J Chest Dis Allied Sci (2009) 0.83
The use of p63 as an effective immunomarker in the diagnosis of pulmonary squamous cell carcinomas on de-stained bronchial lavage cytological smears. Cytopathology (2009) 0.82
Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer. BMC Cancer (2009) 0.80
Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer. Clin Lung Cancer (2010) 0.80
Utility of plasma tumour necrosis factor-alpha and transforming growth factor-beta1 as predictors of survival and treatment outcome in advanced non-small cell lung carcinoma. Biomarkers (2010) 0.80
Prognostic impact of angiogenic markers in non-small-cell lung cancer is related to tumor size. Clin Lung Cancer (2011) 0.79
Molecular profiling of genes in squamous cell lung carcinoma in Asian Indians. Life Sci (2008) 0.78
Immunohistochemical expression of cytosolic phospholipase A2α in non-small cell lung carcinoma. Asian Pac J Cancer Prev (2010) 0.78